Anti-inflammatory and anticancer effects of flavonol glycosides from Diplotaxis harra through GSK3β regulation in intestinal cells
Context and objective: Diplotaxis harra (Forssk.) Boiss. (Brassicaceae) is traditionally used as an antidiabetic, anti-inflammatory or anticancer agent. In these pathologies, the glycogen synthase kinase 3 β (GSK3β) is overactivated and represents an interesting therapeutic target. Several flavonoid...
Main Authors: | Imen Nasri, Rachid Chawech, Cynthia Girardi, Emmanuel Mas, Audrey Ferrand, Nathalie Vergnolle, Nicolas Fabre, Raoudha Mezghani-Jarraya, Claire Racaud-Sultan |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-01-01
|
Series: | Pharmaceutical Biology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/13880209.2016.1230877 |
Similar Items
-
Cucurbitacins from the Leaves of Citrullus colocynthis (L.) Schrad
by: Rachid Chawech, et al.
Published: (2015-09-01) -
Etude phytochimique et activités biologiques de Diplotaxis sp. : application à l'étude des cellules souches coliques pathologiques
by: Nasri, Imen
Published: (2016) -
GSK3β, a Master Kinase in the Regulation of Adult Stem Cell Behavior
by: Claire Racaud-Sultan, et al.
Published: (2021-01-01) -
Regulatory Functions of Nilaparvata lugens GSK-3 in Energy and Chitin Metabolism
by: Yan-Juan Ding, et al.
Published: (2020-11-01) -
GSK3β and the aging kidney
by: Kreidberg, J.A, et al.
Published: (2022)